CRSPCRISPR Therapeutics AG
Chart data are delayed by 15 minutes.
Main metrics
Providers
All 1 issuers →
RealityrCRSP$1.35K100.0%Chains
All 2 chains →
Arbitrum One$1.35K100.0%
Morph—0.0%About CRSP
CRISPR Therapeutics AG is a Swiss biotechnology company focused on gene editing and the development of CRISPR/Cas9-based medicines for serious human diseases. Its research and therapeutic portfolio spans areas such as hemoglobinopathies, oncology, regenerative medicine, autoimmune disorders, and type 1 diabetes. The company’s work centers on using precise genome editing to create targeted cell and gene therapies, with a particular emphasis on advancing treatments derived from its proprietary CRISPR platform. CRISPR Therapeutics AG also collaborates with partners in the life sciences sector to develop and commercialize selected programs, strengthening its role in the broader healthcare innovation landscape. Headquartered in Zug, Switzerland, the company is a notable participant in the biotechnology market, where it contributes to the growing field of gene-based medicine.
Valuation
Profitability
Balance sheet
Trading
| Issuer | Token | Chains | Dividend | Shares | Value | Share |
|---|---|---|---|---|---|---|
| Reality | rCRSPCRISPR Therapeutics (Reality) | | 24.2 | $1.35K | 100.0% |
| Chain | Issuers | Shares | Value | Share |
|---|---|---|---|---|
| Arbitrum One | | 24.2 | $1.35K | 100.0% |
| Morph | | 0 | — | 0.0% |
No dividend has been recorded for this asset.
No corporate event has been recorded for this asset.
